Boston, MA, United States of America

Dongfeng Chen

This inventor holds 1 USPTO granted patent. Top assignees: The Hong Kong Polytechnic University, The Schepens Eye Research Institute, Inc.. Active years: 2023.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Dongfeng Chen. Retrieved from https://idiyas.com/inventor/dongfeng-chen-cig6uuuv

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile


% Patents Active = 100.0

Average Co-Inventor Count = 5.0

ph-index = 1


Company Filing History:


Years Active: 2023

Loading Chart...
1 patent (USPTO):Explore Patents

Title: The Innovations of Dongfeng Chen

Introduction

Dongfeng Chen is an accomplished inventor based in Boston, MA. He has made significant contributions to the field of neuroprotection and immune regulation through his innovative research and patents. His work has the potential to impact the treatment of ocular nerve injuries.

Latest Patents

Dongfeng Chen holds a patent for "Baicalein analogs for use in neuroprotection and regulation of immune reactivity." This patent describes a method of treating an ocular nerve injury in a subject in need thereof, which involves administering a therapeutically effective amount of baicalein or an analog thereof. This innovative approach highlights his commitment to advancing medical treatments.

Career Highlights

Throughout his career, Dongfeng Chen has worked with prestigious institutions, including The Hong Kong Polytechnic University and The Schepens Eye Research Institute, Inc. His experience in these organizations has allowed him to collaborate with leading experts in the field and contribute to groundbreaking research.

Collaborations

Some of his notable coworkers include Chi Wai Do and Chi Ho To. Their collaborative efforts have further enhanced the impact of his research and innovations.

Conclusion

Dongfeng Chen's contributions to the field of neuroprotection and immune regulation through his patent and collaborations demonstrate his dedication to advancing medical science. His work continues to inspire future innovations in the treatment of ocular nerve injuries.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…